Worried about losing muscle on a GLP-1? So was I.
Anyone who’s spent time in GLP-1 groups has heard the advice: start lifting weights early to protect your muscle. I’ve given it myself.
A new randomized trial in Nature Medicine supports the strength training. The reason why, however, turns out to be a bit different from what we’ve thought.
GLP-1 Muscle Loss
The Australian T-REx study followed 120 adults between the ages of 50 and 70 for 40 weeks. Everyone took tirzepatide (the drug in Mounjaro and Zepbound). Half also did supervised, one hour long, resistance training sessions three times a week. The other half stuck to their usual routine.
By the end, the two groups had lost about the same amount, roughly 22 kilograms, or 48 pounds. Lifting didn’t slow their weight loss. Fat loss was 37.9 lbs (17.2 kg) in the drug-only group and 39.6 lbs (18 kg) in the lifting group.
But here’s where the groups split. The drug-only group got weaker on all three strength tests. The lifters, on the other hand, got stronger even while losing weight.
The Independent reported that lifters gained 10% to 18% in upper- and lower-body strength, while the drug-only group lost 6% to 9%. News-Medical’s summary puts the overall gap at about 20% in favor of lifting, with lifters outperforming the other group by around 19.8 lbs (9 kg) on the bench press and 28.6 lbs (13 kg) on the lat pulldown.
So How Much Muscle Did Lifting Save?
Surprisingly, the weight lifting didn’t retain as much muscle as most of us assumed. Total lean soft tissue (muscle, organs, water, and other non-fat tissue) fell by about 10.3 lbs (4.7 kg) without exercise and 7.9 lbs (3.6 kg) with it. That’s about 1.1 kg, or roughly 2.4 pounds, saved, which is a reduction of about 23%.
The researchers estimated skeletal muscle specifically, based on arm and leg measurements. About 5.5 lbs (2.5 kg) were lost in the drug-only group and about 4.4 lbs (2 kg) in the lifting group. That’s roughly a pound of actual muscle, and it’s the figure that’s been making headlines.
Lifters still lost lean tissue. Unsurprisingly so, in my opinion for the exact reason the the authors noted. Some loss is likely normal because a smaller body doesn’t need as much muscle to move itself around.
Why Strength May Matter More Than Size
The lead author, exercise physiologist Daniel Green of the University of Western Australia, has said strength matters more than muscle mass for function and frailty, and the paper says the emphasis should be on building strength.
Why would strength go up when muscle barely does? The experts think the nervous system may be partly responsible. Lifting teaches your brain to recruit muscle fibers more efficiently, and that can raise strength before muscles visibly grow. The exact reason is still being worked out.
An Italian review published last November lines up with this finding as well. It estimates that roughly 15% to 40% of the weight lost on GLP-1 drugs is lean mass, depending on the study, and it found that resistance training does more than aerobic exercise to limit that loss.
What I’m Seeing in Real Life
These results don’t entirely match what I’ve seen in my own real life. I’ve used resistance bands and a kettle bell at home consistently since I started, and I can see the muscle I’ve built.
In addition, I know several other people on GLP-1s who take their weight lifting workouts seriously and have visibly added a large amount of muscle. When you come up with an average across 120 people it can hide a lot of individual variation, and I’d guess the people in my circle are more motivated and consistent than the typical volunteer.
I’d like to see longer studies, and comparisons between different kinds of training: heavy weights versus bands, different intensities, different weekly volumes. For example, the trial doesn’t tell us whether a home resistance-band routine would produce the same strength gains as a supervised program.
The Italian review recommends 2 to 3 resistance sessions a week, 20 to 30 minutes each, using bands, weights, or body-weight exercises. And keep in mind this was a review of existing research and doesn’t compare them.
What the Trial Doesn’t Cover
The folks in the new study were 50 to 70, sedentary, diabetes-free, and all were on tirzepatide. So the results may not apply to younger adults, people who already exercise, people with diabetes or heart disease, or people taking semaglutide.
The benefits for blood pressure, blood sugar, and cholesterol were about the same in both groups, so lifting didn’t add anything there. Eli Lilly supplied the tirzepatide for the trial but provided no other funding, according to News-Medical’s summary, and several authors disclosed financial relationships with drug companies, including Lilly.
Start Lifting Anyway
The trial gives old-timers like me (a year in) in the GLP-1 community something to point to on GLP-1 muscle loss. Losing 48 pounds on tirzepatide made people weaker on average, and three hours a week of lifting reversed that without getting in the way of weight loss.
If you’re newer to this, that’s reason enough to start now, with whatever you have access to. Of course, check with your doctor before beginning a new exercise program, especially if you have joint, heart, or blood pressure issues.







